QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Difficult Risk Minimisation Measures and Adaptation

Test your understanding of the concepts covered by GVP Module XVI: Difficult Risk Minimisation Measures and Adaptation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 What is the most appropriate role of stakeholder feedback in RMM governance?

It replaces formal effectiveness evaluation It provides practical insight that can help explain implementation or behavioural findings It determines the regulatory decision independently of scientific assessment It is relevant only after an RMM has failed

Question 2 of 10 A company wants to replace a paper patient card with a mobile application. Which consideration is most consistent with the article's approach?

Digital delivery is automatically more effective than paper delivery The digital tool should be assessed against the same safety objective, including accessibility, reliability and workflow fit Digital tools eliminate the need for stakeholder engagement Data protection is unrelated to RMM effectiveness

Question 3 of 10 When might withdrawal of an additional RMM be scientifically reasonable?

Whenever the measure creates any administrative burden When the underlying risk is no longer relevant or is adequately controlled by routine measures, supported by appropriate assessment Whenever distribution metrics are high As soon as one evaluation produces an uncertain result

Question 4 of 10 Why is an objective such as 'increase awareness of the risk' generally insufficient for evaluating an RMM?

Awareness cannot be measured in pharmacovigilance It does not specify the relevant population, safety problem or expected behaviour or outcome It automatically requires a controlled clinical trial It focuses too heavily on clinical outcomes

Question 5 of 10 Which statement best describes the relationship between a persistent adverse event rate and RMM effectiveness?

Any continuing event proves the measure failed An effective measure must reduce the event rate to zero Persistent events may be compatible with effectiveness if the objective was risk reduction rather than elimination Persistent events are irrelevant if the measure was distributed

Question 6 of 10 Several marketing authorisation holders provide different safety instructions for products containing the same active substance. What is the principal regulatory and pharmacovigilance concern?

Consistency and coordinated implementation of the safety message may be compromised Product-specific requirements can never be maintained All products must use identical commercial packaging Coordination is unnecessary when the products have the same active substance

Question 7 of 10 Which proposed adaptation best matches a finding that the intended users understand the message but cannot reliably complete the required action within their workflow?

Improve translation only Increase awareness surveys without changing the intervention Modify the workflow, process or tool to address practical barriers Add more technical detail to the communication

Question 8 of 10 Which statement best reflects the MAH's responsibility when distribution and evaluation activities are performed by affiliates and vendors?

Responsibility transfers completely to the vendor performing the activity The MAH should retain sufficient oversight to understand whether the measure functions as intended The QPPV must personally perform every operational activity Only the local affiliate needs access to effectiveness findings

Question 9 of 10 Adverse event counts fall after an RMM is introduced, but product exposure also falls substantially. What is the most important analytical implication?

The RMM should automatically be declared highly effective The reduction may reflect reduced exposure, so attribution to the RMM requires further analysis Exposure changes are irrelevant once an RMM has been implemented The RMM must have caused the exposure decline

Question 10 of 10 A safety communication is consistently sent to prescribers, but the critical risk-control action is performed by laboratory personnel. Which principle has most likely been overlooked?

The need to use only routine risk minimisation measures The need to identify stakeholders according to who controls the critical behaviour The need to evaluate only clinical outcomes The need to avoid adapting measures to national healthcare systems

QPPV.com

Knowledge Assessment: Difficult Risk Minimisation Measures and Adaptation

Cookie Settings